Skip to main content

Table 1 Baseline clinical characteristics of the study patients

From: Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics

n = 1322

Age, years

58 ± 18.1

Male, n (%)

860 (65.1)

BMI, kg/m2

24.4 ± 4.7

Smoking history, n (%)

597 (45.2)

Hypertension, n (%)

449 (34)

Diabetes mellitus, n (%)

263 (19.9)

Malignancy, n (%)

99 (7.5)

COPD, n (%)

64 (4.8)

Hyperuricemia, n (%)

134 (10.1)

Cardiovascular disease, n (%)

114 (8.6)

Chronic liver disease, n (%)

43 (3.3)

Chronic kidney disease, n (%)

91 (6.9)

  1. Data are shown as mean ± SD. Data were compared among groups using analysis of variance (ANOVA) and χ2 tests
  2. BMI, body mass index; COPD, chronic obstructive pulmonary disease